Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2008
10/02/2008CA2680046A1 Methods of diagnosing, classifying and treating endometrial cancer and precancer
10/02/2008CA2679267A1 Compound
10/01/2008EP1975234A2 Therapeutic and diagnotics agents capable of modulating cellular responsiveness to cytokines
10/01/2008EP1975182A1 CD40-binding APC-activating molecules
10/01/2008EP1975181A1 Use of vascular endothelial cell growth factor antagonists
10/01/2008EP1975172A2 High affinity TGFß nucleic acid ligands and inhibitors
10/01/2008EP1975171A1 Anti-tumor agent and immunostimulating agent
10/01/2008EP1975158A1 Novel pyrrole derivatives with histone deacetylase inhibitor activity
10/01/2008EP1974749A1 Cripto blocking antibodies and uses thereof
10/01/2008EP1974747A1 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
10/01/2008EP1974729A1 Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists
10/01/2008EP1974723A2 Secure forms of anti-EGFR antibodies
10/01/2008EP1974048A1 Method for preparing antibodies selective for activating fc receptors
10/01/2008EP1973950A2 Anti-ephb4 antibodies and methods using same
10/01/2008EP1973947A2 Immunoconjugates with improved efficacy for the treatment of diseases
10/01/2008EP1973944A1 Fgf2-binding peptides and uses thereof
10/01/2008EP1973930A2 Cyclic peptides and their use in treating advanced stage neuroblastoma
10/01/2008EP1973914A2 Transforming growth factor modulators
10/01/2008EP1973909A2 Transforming growth factor modulators
10/01/2008EP1973897A2 Substituted pyrymidine derivatives useful in the treatment of cancer and other disorders
10/01/2008EP1973894A2 Method for preparation of amorphous, anhydrous crystalline, or hydrated crystalline docetaxel
10/01/2008EP1973886A2 Prokineticin 1 receptor antagonists
10/01/2008EP1973885A1 Aminopyrimidine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same
10/01/2008EP1973883A2 Novel compounds and methods for their production
10/01/2008EP1973882A1 Piperazine derivatives as farnesyl protein transferase inhibitors
10/01/2008EP1973875A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
10/01/2008EP1973872A1 Inhibitors of histone deacetylase and prodrugs thereof
10/01/2008EP1973569A2 Specific therapy using integrin ligands for treating cancer
10/01/2008EP1973555A2 Processes for obtaining lignan extracts and compositions containing the lignan extracts
10/01/2008EP1973547A1 Compounds having cytokine modulating properties
10/01/2008EP1973545A2 Bicyclic heteroaryl compounds
10/01/2008EP1973398A1 Use of inositol-tripyrophosphate in treating tumors and diseases
10/01/2008EP1641454B1 Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors
10/01/2008EP1635808B1 Topical use of valproic acid for the prevention or treatment of psoriasis and acne
10/01/2008EP1420780B1 Cyclopropyl and cyclobutyl epothilone analogs
10/01/2008EP1372655B1 Cathepsin cysteine protease inhibitors
10/01/2008EP1331935B1 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
10/01/2008EP1091745B1 Treatment of hyperproliferative disorders
10/01/2008EP0766512B1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells
10/01/2008CN101278057A Cancerous disease modifying antibodies
10/01/2008CN101278056A Cancerous disease modifying antibodies
10/01/2008CN101278055A Cancerous disease modifying antibodies
10/01/2008CN101277977A Cancerous disease modifying antibodies
10/01/2008CN101277963A Benzimidazole derivatives as SIRTUIN modulators
10/01/2008CN101277956A Imidazo [1,2-A] pyridine having anti-cell-proliferation activity
10/01/2008CN101277947A 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(l-methylpiperidin-4-ylmethoxy) quinazoline monohydrate
10/01/2008CN101277692A Use of thiazole derivatives and analogues in the treatment of cancer
10/01/2008CN101275136A Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and DNAs encoding the same
10/01/2008CN101275135A Antisense oligonucleotide for tissue-specific regulation of POKEMON gene expression and application thereof
10/01/2008CN101275134A Medicament for curing breast carcinoma and special antisense oligonucleotide therefor
10/01/2008CN101275133A DNA sequence of IER5-coded SiRNA, vector and application thereof
10/01/2008CN101274958A Bioactive peptide, preparation thereof and application thereof
10/01/2008CN101274929A Thrombin receptor antagonists
10/01/2008CN101274928A 3-substituted-4-pyrimidone derivatives
10/01/2008CN101274925A Naphthofurans ortho-quinone compound, preparation and use thereof
10/01/2008CN101274100A Method for preparing adriamycin-dipeptide complexes and applications
10/01/2008CN101274098A Treatment with anti-VEGF antibodies
10/01/2008CN101273989A Berbamine derivative and application of salt thereof
10/01/2008CN101273986A Tripterygium wilfordii diterpene lactone compounds for curing cancer
10/01/2008CN101273977A Preparation technique of tryptanthrin preparations and uses thereof
10/01/2008CN101273972A Method for preparing magnetic adriamycin poly-alkyl-alfa-cyanoacrylate nanoparticles
10/01/2008CN101273969A Compound anticancer sustained-release agent containing Clofarabine
10/01/2008CN101273967A Anticancer sustained-release injection containing neovascularization inhibitor
10/01/2008CN101273966A Temperature controlled sustained-release injection comprising alkyl agent and method for preparing the same
10/01/2008CN101273965A Temperature controlled sustained-release injection containing anti-cancer medicine
10/01/2008CN101273964A Temperature controlled sustained-release injection containing platinum compound
10/01/2008CN101273963A Temperature controlled sustained-release injection containing steroids anti-cancer drugs
10/01/2008CN101273962A Temperature controlled sustained-release injection comprising alkyl agent and method for preparing the same
10/01/2008CN101273773A Health-care Chinese herbal medicine seasoning sauces
10/01/2008CN100422332C Expression and export of angiostation and endostatin as immunofusins
10/01/2008CN100422316C Neutralizing human anti-IGFR antibody
10/01/2008CN100422315C Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
10/01/2008CN100422211C Antagonistic analogs in GH-RH inhibiting IGF-I and -II
10/01/2008CN100422208C Hemiasterlin analogs
10/01/2008CN100422190C Antitumour compound desacetyl fungus epoxyethyl ester and its preparation method
10/01/2008CN100422189C Taspine alkaline preparation method and uses in preparing medicine for treating tumour
10/01/2008CN100422173C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
10/01/2008CN100422172C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
10/01/2008CN100422167C Compound of saturated bicyclic ring in cyclohexanone class, preparation method and application
10/01/2008CN100422158C Inhibitors of Akt activity
10/01/2008CN100422150C 2-hydroxymethyl-3,4,5-trihydroxy-1-(4-pentlyoxybenzyl)piperidine as glucosylceramide synthase (GCS) inhibitor
10/01/2008CN100422149C 2-hydroxymethyl-3,4,5-trihydroxy-1benzylpiperidine derivatives as inhibitors of glucosylceramide synthase (gcs)
10/01/2008CN100421727C Methods
10/01/2008CN100421710C Medicament for treating tumor and ulcer and preparation method thereof
10/01/2008CN100421682C Luhuapan soft capsule and its prepn process
10/01/2008CN100421672C Compound lentinan preparation for antitumour and its preparing method
10/01/2008CN100421665C Mitotic kinesin inhibitors
10/01/2008CN100421661C Method of inducing cancer cell death and tumor regression
10/01/2008CA2654898A1 New chemical compounds
09/2008
09/30/2008US7429663 7-(Pyrimidin-4-yl)-Imidazo[1,2-a]Pyrimidin-5(1H)-ones as GSK3β inhibitors
09/30/2008US7429660 Induce immunology response; anticancer agents
09/30/2008US7429648 IREN protein, its preparation and use
09/30/2008US7429645 Humanized anti-lymphotoxin beta receptor antibodies
09/30/2008US7429644 Comprises lymphotoxin beta receptor (LT-BETA-R) immunoglobulin for treatment of tumor disorders
09/30/2008US7429610 diindole compounds as anticancer agents; potentiation; effective against estrogen-dependent, estrogen-independent, drug-resistant and/or metastasized cancers
09/30/2008US7429603 C-fms kinase inhibitors
09/30/2008US7429596 Oxidoreductase inhibitors; anticancer agents; antiinflammatory agents
09/30/2008US7429595 Inhibiting cyclin-dependent kinase complexes including cdk1/cyclin B, cdk2/cyclin E and cdk4/cyclin D1; preventing apoptosis
09/30/2008US7429592 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor
09/30/2008US7429587 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina
1 ... 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 ... 2211